{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:25:52Z","timestamp":1787570752480,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100019091","name":"Key Research and Development Program of Hunan Province of China","doi-asserted-by":"publisher","award":["2023SK2059"],"award-info":[{"award-number":["2023SK2059"]}],"id":[{"id":"10.13039\/501100019091","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Clinical Key Specialty Construction Project Cardiovascular Department","award":["Z2023123"],"award-info":[{"award-number":["Z2023123"]}]},{"DOI":"10.13039\/501100004761","name":"the Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2021JJ40294"],"award-info":[{"award-number":["2021JJ40294"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Renshu Fund Project of Hunan Provincial People's Hospital","award":["RS2022A12"],"award-info":[{"award-number":["RS2022A12"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-06052-9","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:45:16Z","timestamp":1781527516000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circulating angiopoietin-2 and TEK receptor tyrosine kinase-2 protein provide prognostic value in patients with acute myocardial infarction"],"prefix":"10.1186","volume":"26","author":[{"given":"Siyuan","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihui","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengqi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaofen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"issue":"21","key":"6052_CR1","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1056\/NEJMra1606915","volume":"376","author":"JL Anderson","year":"2017","unstructured":"Anderson JL, Morrow DA. Acute Myocardial Infarction. N Engl J Med. 2017;376(21):2053\u201364.","journal-title":"N Engl J Med"},{"issue":"2","key":"6052_CR2","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1161\/CIR.0000000000000985","volume":"144","author":"AA Damluji","year":"2021","unstructured":"Damluji AA, van Diepen S, Katz JN, Menon V, Tamis-Holland JE, Bakitas M, Cohen MG, Balsam LB, Chikwe J. Mechanical Complications of Acute Myocardial Infarction: A Scientific Statement From the American Heart Association. Circulation. 2021;144(2):e16\u201335.","journal-title":"Circulation"},{"issue":"20","key":"6052_CR3","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1016\/j.jacc.2022.03.353","volume":"79","author":"JA Udell","year":"2022","unstructured":"Udell JA, Jones WS, Petrie MC, Harrington J, Anker SD, Bhatt DL, Hernandez AF, Butler J. Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction: JACC Review Topic of the Week. J Am Coll Cardiol. 2022;79(20):2058\u201368.","journal-title":"J Am Coll Cardiol"},{"key":"6052_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1741-7015-8-34","volume":"8","author":"D Chan","year":"2010","unstructured":"Chan D, Ng LL. Biomarkers in acute myocardial infarction. BMC Med. 2010;8:34.","journal-title":"BMC Med"},{"key":"6052_CR5","doi-asserted-by":"crossref","unstructured":"Duque-Ossa LC, Garc\u00eda-Ferrera B, Reyes-Retana JA. Troponin I as a Biomarker for Early Detection of Acute Myocardial Infarction. Current problems in cardiology. 2021;48(5):101067.","DOI":"10.1016\/j.cpcardiol.2021.101067"},{"key":"6052_CR6","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev-pathmechdis-012418-012827","volume":"14","author":"PV Halushka","year":"2019","unstructured":"Halushka PV, Goodwin AJ, Halushka MK. Opportunities for microRNAs in the Crowded Field of Cardiovascular Biomarkers. Annu Rev Pathol. 2019;14:211\u201338.","journal-title":"Annu Rev Pathol"},{"key":"6052_CR7","doi-asserted-by":"publisher","first-page":"107863","DOI":"10.1016\/j.pharmthera.2021.107863","volume":"227","author":"K Kuwahara","year":"2021","unstructured":"Kuwahara K. The natriuretic peptide system in heart failure: Diagnostic and therapeutic implications. Pharmacol Ther. 2021;227:107863.","journal-title":"Pharmacol Ther"},{"issue":"6","key":"6052_CR8","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/ejhf.1494","volume":"21","author":"C Mueller","year":"2019","unstructured":"Mueller C, McDonald K, de Boer RA, Maisel A, Cleland JGF, Kozhuharov N, Coats AJS, Metra M, Mebazaa A, Ruschitzka F, et al. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations. Eur J Heart Fail. 2019;21(6):715\u201331.","journal-title":"Eur J Heart Fail"},{"issue":"13","key":"6052_CR9","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.jacc.2021.07.045","volume":"78","author":"JW Cunningham","year":"2021","unstructured":"Cunningham JW, Myhre PL. NT-proBNP Response to Heart Failure Therapies: An Imperfect Surrogate. J Am Coll Cardiol. 2021;78(13):1333\u20136.","journal-title":"J Am Coll Cardiol"},{"key":"6052_CR10","doi-asserted-by":"crossref","unstructured":"Khosraviani N, Wu R, Fish JE. Angiopoietin-2: An Emerging Tie to Pathological Vessel Enlargement. Arteriosclerosis, thrombosis, and vascular biology. 2022;42(1):3\u20135.","DOI":"10.1161\/ATVBAHA.121.317102"},{"issue":"9","key":"6052_CR11","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrd.2016.278","volume":"16","author":"P Saharinen","year":"2017","unstructured":"Saharinen P, Eklund L, Alitalo K. Therapeutic targeting of the angiopoietin-TIE pathway. Nat Rev Drug Discovery. 2017;16(9):635\u201361.","journal-title":"Nat Rev Drug Discovery"},{"issue":"3","key":"6052_CR12","first-page":"724","volume":"171","author":"P Saharinen","year":"2017","unstructured":"Saharinen P, Lepp\u00e4nen VM, Alitalo K, SnapShot. Angiopoietins Their Funct Cell. 2017;171(3):724\u2013e724721.","journal-title":"Angiopoietins Their Funct Cell"},{"issue":"11","key":"6052_CR13","doi-asserted-by":"publisher","first-page":"5018","DOI":"10.1172\/JCI99659","volume":"128","author":"SJ Lee","year":"2018","unstructured":"Lee SJ, Lee CK, Kang S, Park I, Kim YH, Kim SK, Hong SP, Bae H, He Y, Kubota Y, et al. Angiopoietin-2 exacerbates cardiac hypoxia and inflammation after myocardial infarction. J Clin Investig. 2018;128(11):5018\u201333.","journal-title":"J Clin Investig"},{"issue":"4","key":"6052_CR14","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1172\/JCI130308","volume":"130","author":"Z Li","year":"2020","unstructured":"Li Z, Korhonen EA, Merlini A, Strauss J, Wihuri E, Nurmi H, Antila S, Paech J, Deutsch U, Engelhardt B, et al. Angiopoietin-2 blockade ameliorates autoimmune neuroinflammation by inhibiting leukocyte recruitment into the CNS. J Clin Investig. 2020;130(4):1977\u201390.","journal-title":"J Clin Investig"},{"issue":"9","key":"6052_CR15","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1172\/JCI84871","volume":"126","author":"M Kim","year":"2016","unstructured":"Kim M, Allen B, Korhonen EA, Nitschk\u00e9 M, Yang HW, Baluk P, Saharinen P, Alitalo K, Daly C, Thurston G, et al. Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation. J Clin Investig. 2016;126(9):3511\u201325.","journal-title":"J Clin Investig"},{"issue":"6","key":"6052_CR16","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.5114\/aoms.2016.62909","volume":"12","author":"H Wu","year":"2016","unstructured":"Wu H, Shou X, Liang L, Wang C, Yao X, Cheng G. Correlation between plasma angiopoietin-1, angiopoietin-2 and matrix metalloproteinase-2 in coronary heart disease. Archives Med science: AMS. 2016;12(6):1214\u20139.","journal-title":"Archives Med science: AMS"},{"issue":"15","key":"6052_CR17","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1161\/CIRCULATIONAHA.119.045158","volume":"142","author":"MY Chan","year":"2020","unstructured":"Chan MY, Efthymios M, Tan SH, Pickering JW, Troughton R, Pemberton C, Ho HH, Prabath JF, Drum CL, Ling LH, et al. Prioritizing Candidates of Post-Myocardial Infarction Heart Failure Using Plasma Proteomics and Single-Cell Transcriptomics. Circulation. 2020;142(15):1408\u201321.","journal-title":"Circulation"},{"issue":"1","key":"6052_CR18","first-page":"1","volume":"33","author":"C Wang","year":"2005","unstructured":"Wang C, Fu P, Li H, Gao R, Xiu R. Soluble angiopoietin receptor Tie-2 in patients with acute myocardial infarction and its effects on angiogenesis. Clin Hemorheol Microcirc. 2005;33(1):1\u201310.","journal-title":"Clin Hemorheol Microcirc"},{"issue":"20","key":"6052_CR19","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","volume":"138","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD. Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018;138(20):e618\u201351.","journal-title":"Circulation"},{"issue":"20","key":"6052_CR20","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","volume":"138","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Circulation. 2018;138(20):e618\u201351.","journal-title":"Circulation"},{"issue":"14","key":"6052_CR21","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1097\/CM9.0000000000000812","volume":"133","author":"SM Chen","year":"2020","unstructured":"Chen SM, Li D, Xing X, Li ZP. Higher serum angiopoietin 2 levels are independently associated with coronary microvascular dysfunction in patients with angina in the absence of obstructive coronary artery disease. Chin Med J. 2020;133(14):1662\u20138.","journal-title":"Chin Med J"},{"issue":"8","key":"6052_CR22","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3109\/1354750X.2012.727028","volume":"17","author":"X Wang","year":"2012","unstructured":"Wang X, Yong H, Mi L, Bai Y, Guo L, Gao W, Cui M, Zhang Y. Changes and significance of serum angiopoietin-2 levels in patients with coronary heart disease. Biomarkers: Biochem Indic exposure response susceptibility chemicals. 2012;17(8):745\u20139.","journal-title":"Biomarkers: Biochem Indic exposure response susceptibility chemicals"},{"key":"6052_CR23","doi-asserted-by":"crossref","unstructured":"Medina-Leyte DJ, Zepeda-Garc\u00eda O, Dom\u00ednguez-P\u00e9rez M, Gonz\u00e1lez-Garrido A, Villarreal-Molina T, Jacobo-Albavera L. Endothelial Dysfunction, Inflammation and Coronary Artery Disease: Potential Biomarkers and Promising Therapeutical Approaches. Int J Mol Sci. 2021;22(8):3850.","DOI":"10.3390\/ijms22083850"},{"issue":"1","key":"6052_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1042\/CS20160129","volume":"131","author":"L Eklund","year":"2017","unstructured":"Eklund L, Kangas J, Saharinen P. Angiopoietin-Tie signalling in the cardiovascular and lymphatic systems. Clin Sci (London England: 1979). 2017;131(1):87\u2013103.","journal-title":"Clin Sci (London England: 1979)"},{"issue":"12","key":"6052_CR25","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1093\/eurjhf\/hft117","volume":"15","author":"R Lorbeer","year":"2013","unstructured":"Lorbeer R, Baumeister SE, D\u00f6rr M, Nauck M, Grotevendt A, V\u00f6lzke H, Vasan RS, Wallaschofski H, Lieb W. Circulating angiopoietin-2, its soluble receptor Tie-2, and mortality in the general population. Eur J Heart Fail. 2013;15(12):1327\u201334.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"6052_CR26","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jacc.2003.08.042","volume":"43","author":"AY Chong","year":"2004","unstructured":"Chong AY, Caine GJ, Freestone B, Blann AD, Lip GY. Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure. J Am Coll Cardiol. 2004;43(3):423\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"6052_CR27","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1681\/ASN.2021060757","volume":"33","author":"SG Mansour","year":"2022","unstructured":"Mansour SG, Bhatraju PK, Coca SG, Obeid W, Wilson FP, Stanaway IB, Jia Y, Thiessen-Philbrook H, Go AS, Ikizler TA, et al. Angiopoietins as Prognostic Markers for Future Kidney Disease and Heart Failure Events after Acute Kidney Injury. J Am Soc Nephrology: JASN. 2022;33(3):613\u201327.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"11","key":"6052_CR28","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1002\/ejhf.342","volume":"17","author":"J P\u00f6ss","year":"2015","unstructured":"P\u00f6ss J, Fuernau G, Denks D, Desch S, Eitel I, de Waha S, Link A, Schuler G, Adams V, B\u00f6hm M, et al. Angiopoietin-2 in acute myocardial infarction complicated by cardiogenic shock\u2013a biomarker substudy of the IABP-SHOCK II-Trial. Eur J Heart Fail. 2015;17(11):1152\u201360.","journal-title":"Eur J Heart Fail"},{"issue":"16","key":"6052_CR29","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1001\/jama.290.16.2174","volume":"290","author":"UN Khot","year":"2003","unstructured":"Khot UN, Jia G, Moliterno DJ, Lincoff AM, Khot MB, Harrington RA, Topol EJ. Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification. JAMA. 2003;290(16):2174\u201381.","journal-title":"JAMA"},{"issue":"5","key":"6052_CR30","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/j.1365-2796.2008.02057.x","volume":"265","author":"JV Patel","year":"2009","unstructured":"Patel JV, Abraheem A, Chackathayil J, Gunning M, Creamer J, Hughes EA, Lip GY. Circulating biomarkers of angiogenesis as indicators of left ventricular systolic dysfunction amongst patients with coronary artery disease. J Intern Med. 2009;265(5):562\u20137.","journal-title":"J Intern Med"},{"issue":"2","key":"6052_CR31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nm1351","volume":"12","author":"U Fiedler","year":"2006","unstructured":"Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G, Gale NW, Witzenrath M, Rosseau S, Suttorp N, et al. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med. 2006;12(2):235\u20139.","journal-title":"Nat Med"},{"key":"6052_CR32","doi-asserted-by":"crossref","unstructured":"Akwii RG, Sajib MS, Zahra FT, Mikelis CM. Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology. Cells. 2019;8(5):471.","DOI":"10.3390\/cells8050471"},{"issue":"2","key":"6052_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1023\/A:1012226627813","volume":"4","author":"P Reusch","year":"2001","unstructured":"Reusch P, Barleon B, Weindel K, Martiny-Baron G, G\u00f6dde A, Siemeister G, Marm\u00e9 D. Identification of a soluble form of the angiopoietin receptor TIE-2 released from endothelial cells and present in human blood. Angiogenesis. 2001;4(2):123\u201331.","journal-title":"Angiogenesis"},{"issue":"19","key":"6052_CR34","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/j.jacc.2008.01.041","volume":"51","author":"SQ Khan","year":"2008","unstructured":"Khan SQ, Dhillon O, Kelly D, Squire IB, Struck J, Quinn P, Morgenthaler NG, Bergmann A, Davies JE, Ng LL. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study. J Am Coll Cardiol. 2008;51(19):1857\u201364.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"6052_CR35","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1124\/pharmrev.120.000096","volume":"73","author":"S Xu","year":"2021","unstructured":"Xu S, Ilyas I, Little PJ, Li H, Kamato D, Zheng X, Luo S, Li Z, Liu P, Han J, et al. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies. Pharmacol Rev. 2021;73(3):924\u201367.","journal-title":"Pharmacol Rev"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06052-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06052-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06052-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:04:11Z","timestamp":1787569451000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06052-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6052"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06052-9","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"1 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted by the Declaration of Helsinki and approved by the Ethics Committee of Hunan Provincial People\u2019s Hospital (2021\u2009\u2212\u2009103). The informed consent was signed by all patients. The study was conducted in accordance with federal guidelines and regulations and the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"735"}}